Biomarin Pharmaceutical (BMRN) Income towards Parent Company (2009 - 2026)
Biomarin Pharmaceutical (BMRN) posted Income towards Parent Company of $44.76 million for Q2 2026, down 81.4% from $240.53 million a year earlier and down 57.6% from the prior quarter.
Powered by 
Analysis
Biomarin Pharmaceutical (BMRN) Income towards Parent Company (2009 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income towards Parent Company at Biomarin Pharmaceutical was $72.97 million, down 88.9% year-over-year; for FY2025, it was $348.9 million, down 18.3% from FY2024.
- Annual Income towards Parent Company shows a five-year compound annual growth rate of -16.4% (FY2020 to FY2025).
- In prior years, Biomarin Pharmaceutical's Income towards Parent Company was $426.86 million in FY2024 (+154.6%), $167.65 million in FY2023 (+18.4%), $141.56 million in FY2022 and -$64.08 million in FY2021.
- Quarterly Income towards Parent Company has run from a low of -$57.9 million in Q4 2021 to a high of $240.53 million in Q2 2025 over five years.
- On a year-over-year basis, Income towards Parent Company increased in four of the last six quarters, with growth averaging 130.9%.
- The strongest year-over-year quarter for Income towards Parent Company in the past five years was Q1 2022, with growth of 595.4%; the weakest was Q2 2026, with a decline of 81.4%.
- According to Business Quant data, Income towards Parent Company for the three prior quarters was $105.53 million (Q1 2026), -$46.57 million (Q4 2025) and -$30.74 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Biomarin Pharmaceutical | 11.07 Bn | 4.93 Bn | 786.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 44.76 Mn |
| Mar 31, 2026 | 105.53 Mn |
| Dec 31, 2025 | -46.57 Mn |
| Sep 30, 2025 | -30.74 Mn |
| Jun 30, 2025 | 240.53 Mn |
| Mar 31, 2025 | 185.69 Mn |
| Dec 31, 2024 | 124.94 Mn |
| Sep 30, 2024 | 106.08 Mn |
| Jun 30, 2024 | 107.17 Mn |
| Mar 31, 2024 | 88.66 Mn |
| Dec 31, 2023 | 20.38 Mn |
| Sep 30, 2023 | 40.38 Mn |
| Jun 30, 2023 | 56.04 Mn |
| Mar 31, 2023 | 50.85 Mn |
| Dec 31, 2022 | -249,000.00 |
| Sep 30, 2022 | -6.65 Mn |
| Jun 30, 2022 | 27.66 Mn |
| Mar 31, 2022 | 120.80 Mn |
| Dec 31, 2021 | -57.90 Mn |
| Sep 30, 2021 | -36.49 Mn |
API Access
Biomarin Pharmaceutical Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=BMRN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "BMRN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=BMRN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();